Article

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics Approach

2021-01-04

Abstract excerpt

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are two most prevalent age-related dementias that severely affect a large number of elderly people around the globe. Poor understanding of pathogenesis of these neurological diseases imposes challenge to discover therapeutic measures and effective diagnosis methods. In this study, a network-based approach was utilized to identify potential common molecular sign...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bdabf6c1-3979-553e-a124-7b939bdc425b
DOI: 10.1101/2020.12.31.424962

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics ApproachDOI 10.1101/2020.12.31.424962Read

CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s DiseaseSemantic proximity Read

Common Dysregulated Pathways and Genes in Alzheimer’s, Parkinson’s, and Huntington’s Diseases: A Computational Analysis to Nominate Candidate Gene Targets for Drug RepurposingSemantic proximity Read

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity Read

Uncovering systems-level molecular similarities between Alzheimer’s and Parkinson’s diseasesSemantic proximity Read

Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer DiseaseSemantic proximity Read

Candidate Genes and MiRNAs Linked to the Inverse Relationship Between Cancer and Alzheimer’s Disease: Insights From Data Mining and Enrichment AnalysisSemantic proximity Read

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspectiveSemantic proximity Read

Identification of Common genes and proteins in Alzheimer’s Disease, Multiple Sclerosis and Duchenne Muscular Dystrophy using in-silico methodsSemantic proximity Read

In-silico analysis: common biomarkers of NDsSemantic proximity Read

Identification of Genetic Markers and Immune Infiltration Characteristics of Alzheimer’s Disease Through Weighted Gene Co-expression Network AnalysisSemantic proximity Read

An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases.Semantic proximity Read

A review and analysis of key biomarkers in Alzheimer’s diseaseSemantic proximity Read